US Patent

US10624879 — Liquid pharmaceutical composition

Formulation · Assigned to Ferring International Center SA · Expires 2034-06-23 · 8y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a physically and chemically stable liquid pharmaceutical composition containing sodium picosulfate, magnesium oxide, citric acid, and malic acid.

USPTO Abstract

The present invention provides a physically and chemically stable pharmaceutical liquid composition including sodium picosulfate, magnesium oxide, citric acid and malic acid and methods of making and using such a composition.

Drugs covered by this patent

Patent Metadata

Patent number
US10624879
Jurisdiction
US
Classification
Formulation
Expires
2034-06-23
Drug substance claim
No
Drug product claim
Yes
Assignee
Ferring International Center SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.